Dec 5, 2022 | Cancer Center News
John Katzenellenbogen, left, Benita Katzenellenbogen and their colleagues found that stimulating estrogen receptor beta in triple-negative breast cancers alters the activity of cancer-related genes and reduces the growth and metastasis of these breast cancers. The...
Feb 2, 2022 | Cancer Center News
Urbana, Ill. – For decades, Katzenellenbogen has focused on understanding breast cancer and women’s health, collaborating with scientists on campus and around the world to develop better treatments and reduce morbidities from the disease. Her research has provided the...
Oct 29, 2021 | Cancer Center News
(L to R): University of Illinois researchers John Katzenellenbogen, Benita Katzenellenbogen, Zeynep Madak-Erdogan, and Sung Hoon Kim showed pathway preferential estrogens may be a safer alternative to hormone replacement therapy. Photo by Seth Turner URBANA, Ill. –...
